Cmed to Demonstrate encapsia at Two Leading Oncology Meetings
13 Nov 2017
Cloud-based Clinical Data Suite to be Showcased at Clinical Operations in Oncology Trials Europe and the ASH Annual Meeting Cmed, an oncology focused, innovative technology-led CRO, today announced that it will showcase its encapsia® clinical data suite at two leading oncology meetings, Clinical Operations in Oncology Trials Europe, taking place 5-6 December in Munich, Germany, and the ASH Annual Meeting, taking place 9-12 December in Atlanta, GA.
As a full-service CRO, Cmed has a strong reputation in delivering complex and demanding clinical trials across numerous oncology types, including various haematological indications, immuno-oncology, breast, lung, prostate and colorectal.
Cmed to Showcase Advanced Data Insights and Analytics Capabilities of encapsia® Clinical Data Suite at Partnerships in Clinical Trials Europe Cmed, an innovative technology-led CRO, will demonstrate its encapsia® clinical data suite at Partnerships in Clinical Trials Europe, taking place 28-29 November 2017 in Amsterdam, The Netherlands. Currently used in trials with nine Pharma companies, including two of the top five, for a variety of electronic data capture (EDC) and direct data capture eSource clinical trials, the solution provides sponsors and their partners with a single point of access for live views of data at any point in a clinical trial.
Rare diseases - still rare disease, but no longer orphans
13 Oct 2017
Historically, rare diseases were also called orphan diseases. They were orphans because no one was developing therapies for them. There was no chance that a company would be able to recover its investment if it spent time and money developing a treatment for such a small population. Some of these diseases are no longer ‘orphans’ in this regard, because the bio-pharmaceutical industry is now ‘adopting’ them slowly, but steadily. Nonetheless, rarity remains the defining feature of these diseases.
Cmed delivers EDC via the Entry app in encapsia®, the first cloud-based suite of apps for the collection, management and analysis of clinical trial data.
The Entry app gives sites the ability to transcribe and view eCRF data using a modern interface with advanced navigation facilities. It’s intuitive, easy to use, and a fully integrated part of the encapsia® suite. The app focuses on making data entry less time-consuming and arduous, featuring modern data entry controls and simple, easy to read screens all designed to help sites when transcribing their data, rather than adding to their workload.